Reply to N.H. Turner et al and Ł. Dziki et al

Affiliations

¹ Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX.
² The University of Texas MD Anderson Cancer Center, Houston, TX.
³ The University of Texas MD Anderson Cancer Center, Houston, TX gchang@mdanderson.org.

Comment

Nader N Massarweh et al. J Clin Oncol. 2015.

. 2015 Apr 20;33(12):1412-3.

doi: 10.1200/JCO.2014.59.9399. Epub 2015 Mar 23.

¹ Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX.
² The University of Texas MD Anderson Cancer Center, Houston, TX.
³ The University of Texas MD Anderson Cancer Center, Houston, TX gchang@mdanderson.org.

No abstract available

Comment on

Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.
Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Massarweh NN, et al. J Clin Oncol. 2014 Sep 20;32(27):2967-74. doi: 10.1200/JCO.2014.55.5334. J Clin Oncol. 2014. PMID: 25092785 Free PMC article.
Do we still need proxies for quality control in rectal cancer surgery?
Dziki Ł, Mroczkowski P. Dziki Ł, et al. J Clin Oncol. 2015 Apr 20;33(12):1411-2. doi: 10.1200/JCO.2014.58.9622. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800771 No abstract available.